Laurus Labs Ltd

LAURUSLABS

Company Profile

  • Business description

    Laurus Labs Ltd is a pharmaceutical company based in India. It provides active pharmaceutical ingredients (API) including intermediates, Generic Finished dosage forms (FDF), and Contract Research services. The entity develops APIs and intermediates for select, high-growth antiretrovirals, Hepatitis C and Oncology. It also manufactures APIs in other therapeutic areas, such as anti-asthma, ophthalmology, anti-diabetics, cardiovascular, and proton pump inhibitors, among others. The company has its business presence in India and Outside India of which it derives a majority of revenue from Outside India. It generates revenue from the sale of API, Intermediates and Formulations, Contract research services, and others.

  • Contact

    Road No. 7, Banjara Hills
    2nd Floor, Serene Chambers
    HyderabadTG500034
    IND

    T: +91 4039804333

    https://www.lauruslabs.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2026

    Employees

    12,467

Stocks News & Analysis

stocks

After Earnings, is Alphabet stock a buy, a sell, or fairly valued?

With a diverse portfolio of innovative technology and integrated media platforms, here’s what we think of Alphabet’s stock.
stocks

Moated ASX share crashes amid weak trading update

Bapcor signalled lower underlying profits for fiscal 2025, while an audit cast doubt on the firm’s past earnings.
stocks

A collection of our best stock opportunities

Our latest articles about where we see opportunities in the market.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,017.9051.200.57%
CAC 407,857.3656.480.72%
DAX 4024,217.37247.011.03%
Dow JONES (US)44,632.99204.57-0.46%
FTSE 1009,136.3254.880.60%
HKSE25,318.77205.68-0.81%
NASDAQ21,098.2980.29-0.38%
Nikkei 22540,610.3164.24-0.16%
NZX 50 Index12,855.9780.44-0.62%
S&P 5006,370.8618.91-0.30%
S&P/ASX 2008,759.0054.400.62%
SSE Composite Index3,627.7017.990.50%

Market Movers